Published on:

Failure To Diagnose Colon Cancer In Syracuse New York To Decrease With Cologuard sDNA Test

According to a recent clinical trial, the newly developed Cologuard sDNA test is better at detecting colon cancer than current non-invasive tests such as the fecal occult blood test.

Researchers report that the sDNA test identified 64% of pre-cancerous polyps and 85% of full-blown cancers. The test measures altered DNA cells in all locations throughout the colon. It is the first non-invasive test to identify pre-cancerous polyps. It requires no bowel preparation.

According to Michael A. Bottar, Esq., a New York colon cancer misdiagnosis lawyer with Bottar Leone, PLLC, a team of Syracuse medical malpractice lawyers, invasive screenings such as a colonoscopy or sigmoidoscopy are currently the “Holy Grail” for detecting colon cancer. Because those studies have risks, gastroenterologists are always searching for a highly accurent, non-invasive alternative.

As there are more than 150,000 cases of colon cancer every year in the United States, the Cologuard sDNA test may go a long way toward timely diagnosing colon cancer and toward eliminating the failure to diagnose colon cancer.

If you believe that your doctor has not acted on your complaints about blood in your stool, constipation, diarrhea, changes in your bowel habits and/or abdominal pain, or if you have been diagnosed with Stage II, III or IV colon cancer, and you would like to know whether your internist, family practitioner, or gastroenterologist could have diagnosed colon cancer sooner, contact us at 1-800-336-5297 or by e-mail at info@bottarleone.com.

Contact Information